Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability of seasonal malaria chemoprevention in Korhogo, Côte d'Ivoire
ISRCTN17164969Phase 4Completed
- Sponsor
- Institut de Recherche en Sciences de la Santé
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulfadoxine + pyrimethamine and amodiaquine in malaria, sponsored by Institut de Recherche en Sciences de la Santé. Primary endpoint: Completion of five monthly SMC treatments. Started Jul 2021; status: completed.
02
Drugs
sulfadoxine + pyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN17164969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17164969.